首页> 外国专利> Marker genes based on doxorubicin treatment for screening of drug inducing cardiotoxicity and screening method using thereof

Marker genes based on doxorubicin treatment for screening of drug inducing cardiotoxicity and screening method using thereof

机译:基于阿霉素治疗的药物诱导的心脏毒性筛选标记基因及其筛选方法

摘要

Marker genes for screening drug inducing cardiotoxicity and a screening method thereof are provided to monitor and determine drugs or chemical substances having the risk of heart toxicity by using the reaction genes selected through a DNA microarray chip. A screening method drug inducing cardiotoxicity comprises (1) a step for processing an object compound in HUVEC; (2) a step for separating RNA from the experimental group cell which processes the object compound of the step (1) and the control cell which does not process the object compound; (3) a step for respectively making the experimental group and control group by different fluorescent materials while synthesizing RNA of the experimental group of the step (2) and the control group to cDNA; (4) a step for mixing the cDNA respectively marked by different fluorescent materials of the step (3) with the DNA microarray; (5) a step for analyzing the DNA reacted microarray of the step (4); and (6) a step for comparing and confirming the expressed grade of the marker gene with the control group.
机译:提供了用于筛选药物诱导的心脏毒性的标记基因及其筛选方法,以通过使用通过DNA微阵列芯片选择的反应基因来监测和确定具有心脏毒性风险的药物或化学物质。药物诱导心脏毒性的筛选方法包括:(1)在HUVEC中处理目标化合物的步骤; (2)从处理步骤(1)的目的化合物的实验组细胞和不处理目的化合物的对照细胞中分离RNA的步骤; (3)在将步骤(2)的实验组和对照组的RNA合成为cDNA的同时,用不同的荧光材料分别制成实验组和对照组的步骤; (4)将分别由步骤(3)的不同荧光材料标记的cDNA与DNA微阵列混合的步骤; (5)分析步骤(4)的DNA反应微阵列的步骤; (6)与对照组比较并确认标记基因的表达等级的步骤。

著录项

  • 公开/公告号KR100901127B1

    专利类型

  • 公开/公告日2009-06-08

    原文格式PDF

  • 申请/专利权人

    申请/专利号KR20070061573

  • 发明设计人 류재천;김연정;송미;이하은;

    申请日2007-06-22

  • 分类号C12Q1/68;

  • 国家 KR

  • 入库时间 2022-08-21 19:11:54

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号